Self-insurance with genetic testing tools
Contenido multimedia no disponible por derechos de autor o por acceso restringido. Contacte con la institución para más información.
| Tag | 1 | 2 | Value |
|---|---|---|---|
| LDR | 00000cab a2200000 4500 | ||
| 001 | MAP20170008644 | ||
| 003 | MAP | ||
| 005 | 20170405151624.0 | ||
| 008 | 170314e20170301esp|||p |0|||b|spa d | ||
| 040 | $aMAP$bspa$dMAP | ||
| 084 | $a344.1 | ||
| 100 | $0MAPA20170003441$aCrainich, David | ||
| 245 | 1 | 0 | $aSelf-insurance with genetic testing tools$cDavid Crainich |
| 520 | $aThe development of genetic testing creates opportunities to better target disease prevention actions. In this article, we determine how the genetic information modifies self-insurance efforts in different health insurance market equilibria with adverse selection. We show that a regulation prohibiting insurers from using genetic information for rate making purposes: cancels the benefits of genetic testing when pooling equilibria occur and does not prevent the exploitation of the benefits derived from genetic testing when separating equilibria (both of the RothschildStiglitz or of the Miyazaki Spence type) prevail in insurance markets. | ||
| 650 | 4 | $0MAPA20080547424$aGenética | |
| 650 | 4 | $0MAPA20080573867$aSeguro de salud | |
| 773 | 0 | $wMAP20077000727$tThe Journal of risk and insurance$dNueva York : The American Risk and Insurance Association, 1964-$x0022-4367$g01/03/2017 Volumen 84 Número 1 - marzo 2017 , p. 73-94 |